Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 9,266 | 5,634 | 8,093 | 4,511 | 5,785 |
| Gross Profit | 9,266 | 5,634 | 8,093 | 4,511 | 5,785 |
| Operating Expenses | 26,286 | 31,518 | 38,094 | 34,481 | 40,218 |
| Operating Income | -17,020 | -25,884 | -30,001 | -29,970 | -34,433 |
| Other Income | 379 | 634 | 957 | 1,193 | 1,261 |
| Pre-tax Income | -16,641 | -25,250 | -29,044 | -28,777 | -33,172 |
| Income Tax | -132 | -182 | -122 | -166 | -330 |
| Net Income Continuous | -16,509 | -25,068 | -28,922 | -28,611 | -32,842 |
| Net Income | $-16,509 | $-25,068 | $-28,922 | $-28,611 | $-32,842 |
| EPS Basic Total Ops | -12.61 | -19.45 | -22.33 | -21.97 | -26.65 |
| EPS Basic Continuous Ops | -12.68 | -19.29 | -22.29 | -22.45 | -26.57 |
| EPS Diluted Total Ops | -12.61 | -19.45 | -22.33 | -21.97 | -26.65 |
| EPS Diluted Continuous Ops | -12.68 | -19.29 | -22.29 | -22.45 | -26.57 |
| EBITDA(a) | $-16,736 | $-25,640 | $-29,858 | $-29,979 | $-34,596 |